Our service areas include:
1. In vitro testing for viral and bacterial pathogens
2. In vivo efficacy, PK and immunogenicity testing
3. Custom assays and protein services including protein synthesis, de novo assay development as well as immunoassays using single and multiplexed platforms.

Our latest addition includes neutralization assay to evaluate antiviral efficacy against Spike-mediated infectivity by SARS-CoV2 variants of concern using pseudotyped viruses. This assay can be customized to test efficacy against new variants of interest for your project.

Our Ph.D level scientists are experts in the field of infectious diseases with hands-on experience. Our team of experts will work with you to ensure you have a robust study design that is the exact right fit to address your research questions. IBT Bioservices has worked on thousands of projects and worked with university labs, small start-ups, and mid-size biotech companies, as well as large pharma companies. We have experience evaluating a range of test articles including small molecules, natural products, immune modulators, biologics as well as therapeutics antibodies.
We have experience with various types of service projects: from initial in vitro and in vivo screening, development and implementation of custom assay or animal models, all the way to multi-year evolving collaborations spanning initial screening to identify lead and hit products to PoC studies using multiple viruses and models to generate data for IND efficacy packages.
We take a collaborative approach to the R&D process and will provide a value added no-obligation free consulting with subject matter experts and customer support.